Even though the suitability of the IFNAR-/- mouse model for SBV vaccination-challenge studies is well established [66], it has to be considered that IFNAR-/- mice are not able to respond to type I interferons and are consequently highly susceptible to viral infections [67]. This evidence concerns the gene IFNAR1 and viral infectious disease.